My Application Form Status

Check the status of your application form with Angel Broking.
  • Companies
  • Everything else
Search
Reliance Defence skids after reporting poor Q1 results
Sep 12,2016

The result was announced on Saturday, 10 September 2016.

Meanwhile, the BSE Sensex was down 408.64 points, or 1.42%, to 28,388.61.

On BSE, so far 4.83 lakh shares were traded in the counter, compared with average daily volume of 5.15 lakh shares in the past one quarter. The stock hit a high of Rs 66.40 and a low of Rs 62.10 so far during the day. The stock hit a 52-week low of Rs 52.65 on 12 February 2016. The stock hit a 52-week high of Rs 114 on 28 December 2015. The stock had underperformed the market over the past one month till 9 September 2016, gaining 0.23% compared with Sensexs 2.54% gain. The scrip had also underperformed the market in past one quarter, gaining 0.08% as against Sensexs 7.6% gain.

The mid-cap company has equity capital of Rs 736.21 crore. Face value per share is Rs 10.

Reliance Defence & Engineerings total income dropped 34.21% to Rs 74.18 crore in Q1 June 2016 over Q1 June 2015.

Reliance Defence & Engineering formerly Pipavav Defence and Offshore Engineering Company is into building defence warships.

Powered by Capital Market - Live News

Bank stocks edge lower
Sep 12,2016

Among public sector banks, Bank of Baroda (down 4.3% at Rs 164.50), Indian Bank (down 3.64% at Rs 220.95), Union Bank of India (down 3.62% at Rs 143.90), Bank of India (down 3.28% at Rs 119.35), State Bank of India (down 3.03% at Rs 256), Punjab National Bank (down 2.76% at Rs 140.90), Canara Bank (down 2.43% at Rs 303.65) and IDBI Bank (down 1.63% at Rs 78.25) declined.

Among private sector banks, Yes Bank (down 4.63% at Rs 1,218.05), Axis Bank (down 3.64% at Rs 590.85), ICICI Bank (down 2.41% at Rs 267.55), IndusInd Bank (down 2.18% at Rs 1,187.55), HDFC Bank (down 1.2% at Rs 1,275) and Kotak Mahindra Bank (down 0.57% at Rs 813.95) edged lower.

The S&P BSE Bankex index was currently down 2.31%. It underperformed the S&P BSE Sensex which was down 425.33 points or 1.48% at 28,371.92.

The S&P BSE Bankex index had outperformed the market over the past one month till 9 September 2016, gaining 7.37% compared with Sensexs 2.54% gain. The index had also outperformed the market in past one quarter, advancing 13.4% as against Sensexs 7.6% gain.

Fitch Ratings has said in a report dated 11 September 2016 that the progressive increase in minimum capital requirements under Basel III is likely to put nearly half of Indian banks in danger of breaching capital triggers. State-run banks are the most at risk, given their poor existing capital buffers and weak prospects for raising capital through market channels, Fitch said. Fitch estimates that Indian banks will require around $90 billion in new capital by FY 2019 to meet Basel III standards, with the state banks accounting for about 80% of the total. According to Fitch, state-run banks will continue to face difficulties in raising capital from the market, which will keep their Viability Ratings under pressure and will weigh on the sector outlook.

Powered by Capital Market - Live News

Siyaram Silk Mills tumbles after weak Q1 numbers
Sep 12,2016

The result was announced on Saturday, 10 September 2016.

Meanwhile, the S&P BSE Sensex was down 423.66 points or 1.47% at 28,373.59.

On BSE, so far 1,813 shares were traded in the counter as against average daily volume of 1,820 shares in the past one quarter. The stock hit a high of Rs 1,270 and a low of Rs 1,170 so far during the day. The stock had hit a 52-week low of Rs 910 on 3 November 2015. The stock had hit a 52-week high of Rs 1,353.25 on 1 September 2016. The stock had outperformed the market over the past one month till 9 September 2016, gaining 21.35% compared with Sensexs 2.54% gain. The scrip had also outperformed the market in past one quarter, advancing 22.11% as against Sensexs 7.6% gain.

The small-cap company has equity capital of Rs 9.37 crore. Face value per share is Rs 10.

Siyaram Silk Mills manufactures and markets textiles, cotton, woollen synthetics and synthetic blends. The company is known for its polyester blended worsted fabrics.

Powered by Capital Market - Live News

Balkrishna Industries gains after reporting good Q1 result
Sep 12,2016

The result was announced on Saturday, 10 September 2016.

Meanwhile, the BSE Sensex was down 393.83 points, or 1.37%, to 28,403.42.

On BSE, so far 7,367 shares were traded in the counter, compared with an average volume of 16,832 shares in the past one quarter. The stock hit a high of Rs 920 so far during the day, which is a record high for the stock. The stock hit a low of Rs 899 so far during the day. The stock hit a 52-week low of Rs 551.35 on 26 February 2016. The stock had outperformed the market over the past one month till 9 September 2016, gaining 21.73% compared with Sensexs 2.54% gain. The scrip had also outperformed the market in past one quarter, gaining 32.41% as against Sensexs 7.6% gain.

The mid-cap company has an equity capital of Rs 19.33 crore. Face value per share is Rs 2.

Balkrishna Industries has given a volume guidance of 1.6 lakh metric tonne to 1.7 lakh metric tonne for the year ending 31 March 2017 (FY 2017). Earnings before interest, tax, depreciation and amortization (EBITDA) margin rose to 28% in Q1 June 2016 compared with 12.8% in Q1 June 2015. For FY 2017, the company has adopted strategy to increase utilization of Bhuj plant gradually, to add new geographies and deepen reach in the existing geographies, increase competitive edge and to repay debt of $92 million.

Balkrishna Industries is a leading manufacturer in the off-highway tire market. It focuses on specialist segments such as agricultural, construction and industrial vehicles as well as earthmoving, port and mining, ATV and gardening applications.

Powered by Capital Market - Live News

Jaypee Infratech slips after reporting reverse turnaround in Q1
Sep 12,2016

The result was announced on Saturday, 10 September 2016.

Meanwhile, the S&P BSE Sensex was down 423.29 points or 1.47% at 28,373.96.

On BSE, so far 30,906 shares were traded in the counter as against average daily volume of 6.77 lakh shares in the past one quarter. The stock hit a high of Rs 9.69 and a low of Rs 9 so far during the day. The stock had hit a record low of Rs 5.34 on 6 June 2016. The stock had hit a 52-week high of Rs 15.15 on 21 October 2015. The stock had outperformed the market over the past one month till 9 September 2016, gaining 10.79% compared with Sensexs 2.54% gain. The scrip had also outperformed the market in past one quarter, surging 60.85% as against Sensexs 7.6% gain.

The mid-cap company has equity capital of Rs 1388.93 crore. Face value per share is Rs 10.

Jaypee Infratechs total income jumped 113.64% to Rs 1099.33 crore in Q1 June 2016 over Q1 June 2015.

Jaypee Infratech (JIL) is an infrastructure development. JIL a subsidiary of the Jaypee Group.

Powered by Capital Market - Live News

HDIL slides after reporting weak Q1 results
Sep 12,2016

The result was announced on Saturday, 10 September 2016.

Meanwhile, the BSE Sensex was down 440.73 points, or 1.53%, to 28,356.52.

On BSE, so far 40,604 shares were traded in the counter, compared with an average volume of 12.95 lakh shares in the past one quarter. The stock hit a high of Rs 96.05 and a low of Rs 93.80 so far during the day.

Housing Development and Infrastructure (HDIL) said that it follows project completion method and accordingly results on quarter to quarter basis may not be comparable.

HDIL is a real estate development company, with significant operations in the Mumbai Metropolitan Region.

Powered by Capital Market - Live News

IRB Infra corrects on profit booking
Sep 09,2016

Meanwhile, the BSE Sensex was down 248.03 points, or 0.85%, to 28,797.25.

On BSE, so far 4.25 lakh shares were traded in the counter, compared with average daily volume of 2.41 lakh shares in the past one quarter. The stock hit a high of Rs 254.55 and a low of Rs 244.40 so far during the day. The stock hit a 52-week high of Rs 272.20 on 20 October 2015. The stock hit a 52-week low of Rs 197 on 24 June 2016. The stock had outperformed the market over the past 30 days till 8 September 2016, rising 22.09% compared with 4.57% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 17.70% as against Sensexs 9.05% rise.

The mid-cap company has equity capital of Rs 351.45 crore. Face value per share is Rs 10.

Shares of IRB Infrastructure Developers rose 11.33% in five trading sessions to settle at Rs 252.05 yesterday, 8 September 2016, from its close of Rs 226.40 on 31 August 2016.

The stock jumped 9.11% to Rs 252.05 yesterday, 8 September 2016, after an investment trust backed by the company filed a draft offer document with the market regulator for an initial public offer. The announcement was made during trading hours yesterday, 8 September 2016.

IRB Infrastructure Developers is the sponsor of the IRB InvIT Fund (the Trust), an infrastructure investment trust registered with the Securities and Exchange Board of India (Sebi).

IRB Infrastructure, a wholly-owned subsidiary of the company and the investment manager to the Trust, has filed a draft offer document dated 7 September 2016, in relation to an initial public offer (IPO) of units representing an undivided beneficial interest in IRB InvIT Fund, with Sebi.

The IPO consists of a fresh issue of units, aggregating up to Rs 4300 crore, by IRB InvIT Fund (the fresh issue), and an offer for sale of units by the company and certain of its subsidiaries, namely Modern Road Makers, Aryan Toll Road, ATR Infrastructure and Ideal Road Builders. The investment manager reserves the option to retain oversubscription of up to 25% of the issue size in accordance with the InvIT Regulations.

Media reports suggested that the proposed IPO will unlock the investment value of IRB Infrastructure subsidiaries and boost the book value of the company.

On a consolidated basis, net profit of IRB Infrastructure Developers rose 10.41% to Rs 181.84 crore on 36.83% rise in net sales to Rs 1517.33 crore in Q1 June 2016 over Q1 June 2015.

IRB Infrastructure Developers is an integrated infrastructure development and construction company with significant experience in toll roads and highways sector. The company is one of the largest private developers in India.

Powered by Capital Market - Live News

Kaya jumps after acquisition
Sep 09,2016

The announcement was made during trading hours today, 9 September 2016.

Meanwhile, the BSE Sensex was down 228.98 points, or 0.79%, to 28,816.30.

On BSE, so far 40,000 shares were traded in the counter, compared with average daily volume of 4,543 shares in the past one quarter. The stock hit a high of Rs 777.95 and a low of Rs 692 so far during the day. The stock hit a 52-week high of Rs 1,287.50 on 21 December 2015. The stock hit a 52-week low of Rs 688.20 on 12 August 2016. The stock had underperformed the market over the past 30 days till 8 September 2016, falling 5.03% compared with 4.57% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 12.98% as against Sensexs 9.05% rise.

The small-cap company has equity capital of Rs 12.95 crore. Face value per share is Rs 10.

Kaya said that its foreign subsidiary, Kaya Middle East, DMCC, has entered into an agreement dated 8 September 2016 for acquiring 75% beneficial interest in Minal Medical Centre, Dubai and Minal Specialized Clinic Dermatology, Sharjah. However, the agreement will become effective on fulfilling of certain conditions precedent and obtaining the requisite statutory approvals, which will take approximately 4 months.

The above said entities carry out business of skincare, body & hair services and reported revenue of 11.17 million Dirham, as per the audited financial statements for the year ended 31 December 2015.

Kaya said that this acquisition will further strengthen its network of clinics in the United Arab Emirates (UAE) region and add new set of customers to its existing base in the region. With its special expertise in body contouring, it would help Kaya in leveraging across the region. With this acquisition, the total network of the clinics in the Middle East region would increase to 23.

On a consolidated basis, Kaya reported net loss of Rs 0.31 crore in Q1 June 2016 compared with net profit of Rs 1.42 crore in Q1 June 2015. Net sales rose 16.39% to Rs 97.91 crore in Q1 June 2016 over in Q1 June 2015.

Kaya, Maricos wholly-owned subsidiary, delivers skin care solutions in India and overseas, through its range of Kaya Skin Cinics.

Powered by Capital Market - Live News

Timken India gains after good Q1 results
Sep 09,2016

The result was announced during trading hours today, 9 September 2016.

Meanwhile, the BSE Sensex was down 148.63 points, or 0.51%, to 28,896.65.

On BSE, so far 40,000 shares were traded in the counter, compared with average daily volume of 6,514 shares in the past one quarter. The stock hit a high of Rs 593 and a low of Rs 565 so far during the day. The stock hit a 52-week high of Rs 632 on 8 October 2015. The stock hit a 52-week low of Rs 400.50 on 18 March 2016. The stock had underperformed the market over the past 30 days till 8 September 2016, rising 0.88% compared with 4.57% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 4.58% as against Sensexs 9.05% rise.

The mid-cap company has equity capital of Rs 68 crore. Face value per share is Rs 10.

Timken India manufactures anti-friction bearings.

Powered by Capital Market - Live News

Reliance Defence corrects on profit booking
Sep 09,2016

Meanwhile, the BSE Sensex was down 185.53 points, or 0.64%, to 28,859.75.

On BSE, so far 10.64 lakh shares were traded in the counter, compared with average daily volume of 4.86 lakh shares in the past one quarter. The stock hit a high of Rs 70 and a low of Rs 64.95 so far during the day. The stock hit a 52-week high of Rs 114 on 28 December 2015. The stock hit a 52-week low of Rs 52.65 on 12 February 2016. The stock had outperformed the market over the past 30 days till 8 September 2016, rising 7.49% compared with 4.57% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 9.46% as against Sensexs 9.05% rise.

The mid-cap company has equity capital of Rs 736.21 crore. Face value per share is Rs 10.

Shares of Reliance Defence & Engineering rose 8.08% in four trading sessions to settle at Rs 68.85 yesterday, 9 September 2016, from its close of Rs 63.70 on 1 September 2016.

Reliance Defence & Engineering reported net profit of Rs 102.44 crore in Q1 March 2016 as against net loss of Rs 158.28 crore in Q1 March 2015. Net sales rose 89.26% to Rs 93.42 crore in Q4 March 2016 over Q4 March 2015.

Reliance Defence & Engineering formerly Pipavav Defence and Offshore Engineering Company is into building defence warships.

Powered by Capital Market - Live News

Aviation stocks slide as crude oil prices jump
Sep 09,2016

SpiceJet (down 4.77% at Rs 60.95), Jet Airways (India) (down 0.94% at Rs 542.40) and InterGlobe Aviation (down 0.85% at Rs 861.35), edged lower.

Meanwhile, the S&P BSE Sensex was down 234.66 points or 0.81% at 28,810.62.

In the global commodities markets, Brent crude oil futures for November settlement was currently down 59 cents at $49.40 a barrel. The contract had surged $2.01 a barrel or 4.18% to settle at $49.99 a barrel during the previous trading session after data showed a surprisingly huge weekly drop in US crude stock piles.

Higher crude oil prices hurt aviation firms as jet fuel prices, which typically constitute over 40% of airlines operating costs, are directly linked to international crude oil prices.

Powered by Capital Market - Live News

Puravankara Projects slips after reporting dismal Q1 numbers
Sep 09,2016

The result was announced after market hours yesterday, 8 September 2016.

Meanwhile, the S&P BSE Sensex was down 225.47 points or 0.78% at 28,819.81.

On BSE, so far 57,069 shares were traded in the counter as against average daily volume of 44,680 shares in the past one quarter. The stock hit a high of Rs 51.95 and a low of Rs 50.40 so far during the day. The stock had hit a 52-week low of Rs 42.10 on 12 February 2016. The stock had hit a 52-week high of Rs 68.90 on 15 October 2015. The stock had outperformed the market over the past one month till 8 September 2016, gaining 15.54% compared with Sensexs 3.06% gains. The scrip had also outperformed the market in past one quarter, rising 13.85% as against Sensexs 7.49% gains.

The small-cap realty firm has equity capital of Rs 118.57 crore. Face value per share is Rs 5.

Puravankara Projects consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) margin rose to 26% in Q1 June 2016 from 23% in Q1 June 2015. Puravankara Projects said that sales realisation of ongoing projects for Puravankara and Provident in Q1 June 2016 stood at Rs 6,070 per square feet (sq.ft.) and Rs 4,128 per sq. ft. respectively. Sales of ready to move in and ongoing including new launches rose 45% to 5.7 lakh sq ft in area terms and increased 60% to Rs 314 crore in value terms in Q1 June 2016 over Q1 June 2015. The projects under development stood at 22.08 million square feet as on 30 June 2016. The launch pipeline stands at 11.36 million square feet under both the Puravankara and Provident brands, across Kochi, Bengaluru, Chennai and Mumbai.

Ashish Puravankara, Managing Director, Puravankara Projects said that the company is witnessing a strengthening of its business as compared to earlier periods on project deliveries, collections, accelerated sales from ready to move in and a favourable balance collections namely, balance costs to go owing to many of its current projects having sold over 50%.

Puravankara Projects is a leading real estate company in India, with significant presence in Bengaluru, Kochi, Chennai, Coimbatore, Hyderabad and Mysore.

Powered by Capital Market - Live News

IDBI Bank jumps on buzz ADB may buy stake
Sep 09,2016

Meanwhile, the BSE Sensex was down 241.12 points, or 0.83%, to 28,804.16.

On BSE, so far 22.37 lakh shares were traded in the counter, compared with average daily volume of 7.04 lakh shares in the past one quarter. The stock hit a high of Rs 80.25 and a low of Rs 76.20 so far during the day. The stock hit a 52-week high of Rs 95.70 on 3 December 2015. The stock hit a 52-week low of Rs 47.40 on 12 February 2016. The stock had outperformed the market over the past 30 days till 8 September 2016, rising 13.26% compared with 4.57% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 13.86% as against Sensexs 9.05% rise.

The large-cap company has equity capital of Rs 2,058.82 crore. Face value per share is Rs 10.

According to media reports, multilateral agency Asian Development Bank (ADB) has held talks with the government to acquire stake in IDBI Bank as negotiations with World Bank arm International Financial Corporation (IFC) have slowed down.

ADB, along with IFC and Commonwealth Development Corporation (CDC) were in the fray to buy into IDBI Bank, where the government is open to cutting its stake below 51%, something it cant do in other state-run lenders, given restrictions imposed by the law. ADB is expected to acquire 10-15% stake in the bank, reports added.

The government is looking to reduce its stake in IDBI Bank as part of a strategy to rework its functioning as it is seen to have fallen short of expectations. Despite being saddled with legacy assets, the bank has been a perpetual test case for the government since liberalisation n++ the last one being modelling it on the lines of ICICI Bank in what was seen as a transformation.

The Government of India currently holds 73.98% stake in IDBI Bank (as per the shareholding pattern as on 30 June 2016).

IDBI Banks net profit rose 78.35% to Rs 241.10 crore on 4% growth in operating income to Rs 8219.43 crore in Q1 June 2016 over Q1 June 2015.

Powered by Capital Market - Live News

Suven Life Sciences gains after securing three product patents
Sep 09,2016

The announcement was made during market hours today, 9 September 2016.

Meanwhile, the BSE Sensex was down 215.31 points, or 0.74%, to 28,829.97.

Higher than normal volumes were witnessed on the counter. On BSE, so far 99,636 shares were traded in the counter, compared with average daily volume of 61,833 shares in the past one quarter. The stock hit a high of Rs 205.10 and a low of Rs 196.20 so far during the day. The stock hit a 52-week high of Rs 308.70 on 5 October 2015. The stock hit a 52-week low of Rs 144.35 on 19 February 2016. The stock had underperformed the market over the past one month till 8 September 2016, falling 2.07% compared with Sensexs 3.06% gains. The scrip had also underperformed the market in past one quarter, dropping 6.7% as against Sensexs 7.49% gains.

The mid-cap company has equity capital of Rs 12.73 crore. Face value per share is Re 1.

Suven Life Sciences announced that it was granted one product patent from Canada, one product patent from Europe and one product patent from Hong Kong corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases. These patents are valid through 2030, 2032 and 2032 respectively.

The granted claims of the patents are from the mechanism of action include the class of selective 5-HT4 compounds and H3 Inverse agonist compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimers disease, Attention deficient hyperactivity disorder (ADHD), Huntingtons disease, major depressive disorder (MDD), Parkinson and Schizophrenia.

With these new patents, Suven has a total of twenty four granted patents from Canada, twenty two granted patents from Europe and twenty one granted patents from Hong Kong. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts. Products out of these inventions may be outlicensed at various phases of clinical development like at Phase-I or Phase-II, Suven Life said.

Suven Life Sciences consolidated net profit rose 58.2% to Rs 32.58 crore on 31.7% rise in net sales to Rs 133.23 crore in Q1 June 2016 over Q1 June 2015.

Suven Life Sciences is a biopharmaceutical company specializing in drug discovery and developmental activities in central nervous system disorders and contract research and manufacturing services (CRAMS).

Powered by Capital Market - Live News

Hindustan Composites spurts after strong Q1 earnings
Sep 09,2016

The result was announced after market hours yesterday, 8 September 2016.

Meanwhile, the BSE Sensex was down 227.01 points, or 0.78%, to 28,818.27.

On BSE, so far 6,161 shares were traded in the counter, compared with average daily volume of 343 shares in the past one quarter. The stock hit a high of Rs 1,591.25 so far during the day, which is also a record high for the counter. The stock hit a low of Rs 1,399 so far during the day. The stock hit a 52-week low of Rs 750 on 8 April 2016. The stock had underperformed the market over the past 30 days till 8 September 2016, rising 3.68% compared with 4.57% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 18.61% as against Sensexs 9.05% rise.

The small-cap company has equity capital of Rs 4.92 crore. Face value per share is Rs 10.

Hindustan Composites is a pioneer in the development, manufacture & marketing of industrial products and friction materials in India.

Powered by Capital Market - Live News